ClinicaliQ Trial Snapshot
- EMBRACE Tremor BiFUS — Recruiting • Non-phase study • NCT06974916.
- Staged bilateral focused ultrasound thalamotomy added to medication improves tremor control compared to medication alone in patients with prior unilateral treatment.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This is a post-market (Phase IV) randomized, controlled, blinded, multicenter study with the aim to determine the added value of staged bilateral Exablate thalamotomy compared to a group of patients on previous unilateral treatment combined with local standard medical treatment. Conditions: Essential Tremor Interventions: Staged bilateral Exablate thalamotomy, Local standard medical treatment after previous Exablate unilateral thalamotomy. Lead Sponsor: InSightec Planned Enrollment: 100 participants